New answer by Radiation Oncologist at University of Arkansas for Medical Sciences (January 17, 2026)
Before launching into XRT for this CNS patient, I would review with Sarcoma Med Onc regarding initial treatment with an antiangiogenic agent. SFTs have a relatively high rate ...